Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Ophthalmologe ; 103(1): 48-51, 2006 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-15538583

RESUMO

BACKGROUND: The prevalence of intraocular metastases from breast cancer is approximately 4-5%. Solitary metastases of the iris are rare. We report on successful treatment of a solitary iris metastasis using electron beam irradiation. CASE REPORT: A 30-year-old patient presented with an amelanotic tumor of the iris and the anterior chamber angle of her right amblyopic eye. The patient had undergone left-sided breast-conserving surgery and lymph node dissection 3 years before followed by chemotherapy and radiotherapy. The iris tumor was considered a metastasis. Fractionated electron beam irradiation was performed applying a total dose of 50 Gy in fractions of 5 x 2 Gy/week, electrons (9 MeV). The iris metastasis was completely resolved 13 months after radiotherapy. Until now no signs of cataract have been detected and visual acuity has remained stable. CONCLUSION: Electron beam irradiation of this iris metastasis was an effective treatment for preserving visual acuity and ocular function with tolerable acute toxicity and so far no adverse side effects.


Assuntos
Neoplasias da Mama/radioterapia , Elétrons/uso terapêutico , Neoplasias da Íris/radioterapia , Neoplasias da Íris/secundário , Adulto , Feminino , Humanos , Metástase Linfática , Resultado do Tratamento
2.
J Neurooncol ; 74(2): 167-71, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16193388

RESUMO

PURPOSE: To assess the feasibility, efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent glioblastoma multiforme. PATIENTS AND METHODS: From January 1995 to July 2003, 53 patients with histologically proven glioblastoma multiforme were treated at recurrence with fractionated stereotactic radiation therapy. A median dose of 36 Gy using a median fractionation of 5 x 2 Gy/week was applied. RESULTS: Median overall survival was 21 months, and median overall survival from the time point of re-irradiation was 8 months. The median time interval between primary and secondary radiation therapy was 10 months. In this patient population, no variables predicting longer overall survival could be determined. However, neurosurgical resection at relapse was associated with increased survival after re-irradiation (p=0.04), but left progression-free survival unaltered. Treatment was well-tolerated and no severe toxicities developed. CONCLUSION: Stereotactically guided fractionated re-irradiation is a safe and effective treatment modality in selected cases of recurring glioblastoma multiforme. Since this is not a randomized study, further evaluation in larger patient collectives is warranted. Also, based on recent results of radiochemotherapy in the treatment of primary glioblastoma multiforme, concomitant chemotherapy at relapse might be considered in the future.


Assuntos
Neoplasias Encefálicas/radioterapia , Glioblastoma/radioterapia , Recidiva Local de Neoplasia/radioterapia , Neoplasias Encefálicas/cirurgia , Fracionamento da Dose de Radiação , Estudos de Viabilidade , Feminino , Raios gama , Glioblastoma/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Retratamento , Estudos Retrospectivos , Técnicas Estereotáxicas/instrumentação , Taxa de Sobrevida
3.
Onkologie ; 27(2): 166-8, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15138350

RESUMO

CASE HISTORY AND FINDINGS: A 35-year-old male patient presented with a 1-year history of hesitancy in voiding. An urethrogram revealed urethral stricture, therefore an urethrotomy with biopsies was performed. Histologic results suggested the diagnosis of extramedullary mature plasmocytoma. TREATMENT AND OUTCOME: After external beam radiotherapy with a total dose of 45 Gy the patient is disease-free without any therapy-related late effects after a follow-up of 36 months. CONCLUSION: Primary localization of extramedullar plasmocytomas in the genitourinary tract is very rare. This case report discusses a case of a male patient suffering from plasmocytoma of the urethra, who could be treated successfully by primary external beam radiotherapy.


Assuntos
Plasmocitoma/diagnóstico , Plasmocitoma/radioterapia , Neoplasias Uretrais/diagnóstico , Neoplasias Uretrais/radioterapia , Adulto , Diagnóstico Diferencial , Humanos , Masculino , Plasmocitoma/complicações , Resultado do Tratamento , Neoplasias Uretrais/complicações , Transtornos Urinários/diagnóstico , Transtornos Urinários/etiologia
4.
Orthopade ; 31(2): 156-64, 2002 Feb.
Artigo em Alemão | MEDLINE | ID: mdl-11963481

RESUMO

Sonography is an integral part of primary tumor diagnosis and follow-up for the great majority of organ systems. However, its value in the field of space-occupying processes of the locomotor system, especially of malignant bone tumors, has mostly been underestimated. The sonographic examination has to investigate the whole tumor region and the corresponding lymph nodes statically and dynamically. The examination procedure should be standardized and the documentation reliable. Evaluation criteria are the localization, dimensions, and volume of the tumors, echogenicity and homogeneity, peri- and intratumoral vascularization (vessel density and architecture), borders of the tumor, and neighboring structures. Pathologic changes not only of the soft tissues but also of the bones can be evaluated sonographically. Even subtle analysis does not permit definitive assessment of tumor status. Taking its physical limitations into consideration, high-resolution sonography, enhanced by color/PowerDoppler and three-dimensional techniques, is a valuable adjunct to improve diagnosis, therapy planning, monitoring, and posttherapeutic care of tumors of the locomotor system.


Assuntos
Neoplasias Ósseas/diagnóstico por imagem , Imageamento Tridimensional , Leiomiossarcoma/diagnóstico por imagem , Metástase Linfática/diagnóstico por imagem , Neoplasias de Tecidos Moles/diagnóstico por imagem , Ultrassonografia Doppler em Cores , Neoplasias Ósseas/secundário , Neoplasias da Mama , Diagnóstico Diferencial , Feminino , Seguimentos , Humanos , Leiomiossarcoma/secundário , Monitorização Fisiológica , Neoplasias de Tecidos Moles/secundário , Software , Fatores de Tempo
5.
Strahlenther Onkol ; 177(6): 296-301, 2001 Jun.
Artigo em Alemão | MEDLINE | ID: mdl-11446318

RESUMO

BACKGROUND: Radiotherapy is potentially curative in early stages of follicle center lymphoma. Frequent side effects are pancytopenia, nausea and abdominal discomfort. A radiation-induced liver injury with serious clinical symptoms and changes in liver function is a rare complication. CASE REPORT: Whole abdomen was irradiated in a 49-year-old patient with a centrocytic-centroblastic lymphoma, stage IA (localization: left inguinal region). A total dose of 30 Gy was delivered in a weekly fractionation of five times 1.5 Gy. Kidneys were protected by shielding after a dose of 13.5 Gy, liver blocks were positioned after 25 Gy. During the last 2 days of therapy the patient presented with weight gain, ascites, dyspnoea and elevated liver enzymes. Diagnostics revealed hepatosplenomegaly, ascites and an increased portosystemic pressure gradient. Liver biopsy specimen showed a veno-occlusive disease. Complete relief of symptomatology was achieved within 7 days following placement of a transjugular intrahepatic portosystemic stent-shunt (TIPSS), heparinization and diuretics. Liver enzymes are in the normal range. CONCLUSION: Veno-occlusive disease of the liver (VOD) is a very rare side effect of primary abdominal irradiation of follicle center lymphoma. This complication should be taken into consideration if a patient presents with upper right quadrant pain, ascites and elevation of liver enzymes especially within 4 months following radiotherapy. Genesis of veno-occlusive disease, diagnostics, therapy and a review of the literature are presented.


Assuntos
Circulação Hepática/efeitos da radiação , Fígado/irrigação sanguínea , Irradiação Linfática/efeitos adversos , Irradiação Linfática/métodos , Linfoma Folicular/radioterapia , Insuficiência Venosa/etiologia , Angiografia , Ascite/etiologia , Quimioterapia Adjuvante , Diafragma , Fracionamento da Dose de Radiação , Virilha , Humanos , Fígado/diagnóstico por imagem , Fígado/enzimologia , Linfoma Folicular/diagnóstico por imagem , Linfoma Folicular/tratamento farmacológico , Linfoma Folicular/patologia , Masculino , Pessoa de Meia-Idade , Derivação Portossistêmica Transjugular Intra-Hepática , Radioterapia Adjuvante , Tomografia Computadorizada por Raios X , Insuficiência Venosa/complicações , Insuficiência Venosa/cirurgia
6.
Semin Surg Oncol ; 20(1): 13-23, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11291128

RESUMO

Astrocytomas account for the majority of primary brain tumors. Low-grade tumors are slowly growing tumors with relatively long overall survival. However, a high percentage of these tumors transform to more malignant, high-grade tumors. High-grade gliomas (anaplastic astrocytomas and glioblastoma multiforme) have a poor prognosis. Treatment options are capable of prolonging the natural history of the disease, but the long-term survival is poor. This review discusses the different postoperative treatment options and the prognostic factors in low- and high-grade astrocytomas.


Assuntos
Astrocitoma/radioterapia , Neoplasias Encefálicas/radioterapia , Adolescente , Adulto , Astrocitoma/fisiopatologia , Neoplasias Encefálicas/fisiopatologia , Criança , Humanos , Pessoa de Meia-Idade , Cuidados Pós-Operatórios , Prognóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA